Insider Trading Activity For Kala Pharmctls (NASDAQ:KALA)
Longitude Capital Partners Ii, , Major Shareholder of Kala Pharmctls (NASDAQ:KALA) reportedly Bought 215,000 shares of the company’s stock at an average price of 15 for a total transaction amount of $3,225,000.00 SEC Form
Analyst Ratings For Kala Pharmctls (NASDAQ:KALA)
These are No ratings tracked in the last 12 months. .
The current consensus rating for Kala Pharmctls (NASDAQ:KALA) is N/A (Score: NaN) with a consensus target price of N/A
Recent Trading Activity for Kala Pharmctls (NASDAQ:KALA)
Shares of Kala Pharmctls closed the previous trading session at 20.15 up +1.17 6.16% with 526,440 shares trading hands.